MedTrace Logo

Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates

NCT01519570 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2589

Last updated 2019-02-01

Study results available
· View outcomes & findings →

Summary

Despite the significant benefits of herpes zoster vaccine (HZV), vaccination rates remain low. Electronic medical records (EMR) can serve as a practical strategy to better facilitate the application of preventative health care, such as increasing immunization rates. A new care model that can increase the herpes zoster vaccination rate, as well as other preventative health services, is warranted. The objective of this study is to investigate if the functions of an EMR, in combination with a pharmacist as part of the care team, can improve the herpes zoster vaccination rate.

Conditions

  • Herpes Zoster Disease

Interventions

OTHER

An informational packet regarding shingles and the HZV was sent to patients identified by the EMR

The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription.

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Stuart J Beatty, PharmD · Ohio State University

  • Shelley H Otsuka, PharmD · The Ohio State Univeristy

  • Neeraj H Tayal, MD · Ohio State University

  • Kyle Porter, MAS · Ohio State University

  • Peter J Embi, MD, MS · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01519570 on ClinicalTrials.gov